Novel hypolipidemic bempedoic acid safe in diabetics, may overcome shortcomings of statins: Lancet
Statins reduce LDL cholesterol and cardiovascular events among those with or without diabetes but have been reported to increase new-onset diabetes. A prespecified analysis of CLEAR outcomes trial published recently in The Lancet journal has shown that unlike statins, bempedoic acid is not associated with an increased risk of new-onset diabetes, even in those in […]